Abstract |
Oral carcinoma is a serious public health problem and the leading cause of head and neck cancer mortality worldwide. Moreover, oral cancer patients often present symptoms at a late stage and show a high recurrence rate after treatment. Therefore, there is an urgent need to identify novel biomarkers for early diagnosis or clinical oral cancer therapy. In this study, we employed a subset of lentiviral short hairpin RNAs targeted against various kinases and phosphatases, designed by The RNAi Consortium, to screen systemically and in a high-throughput manner for potential growth regulators of oral cancer cells. The screen revealed a total of 50 candidate genes, for which more than 90% of growth inhibition in human oral squamous cancer HSC-3 cells was obtained. Furthermore, bioinformatic analysis of these candidate genes identified transforming growth factor-β receptor type II- and fms-related tyrosine kinase 3-related molecular pathways that are involved in NF-κB-mediated growth of HSC-3 cells. These candidate genes may be potential biomarkers for early diagnosis of oral cancer. In addition, these candidate genes represent potential targets for anticancer drug design helping to develop a personalized treatment to combat oral cancer.
|
Authors | Ming-Han Yeh, Tzung-Chieh Tsai, Han-Peng Kuo, Nai-Wen Chang, Miao-Rong Lee, Jing-Gung Chung, Ming-Hsui Tsai, Jah-Yao Liu, Ming-Ching Kao |
Journal | International journal of oncology
(Int J Oncol)
Vol. 39
Issue 5
Pg. 1221-31
(Nov 2011)
ISSN: 1791-2423 [Electronic] Greece |
PMID | 21720705
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers, Tumor
- NF-kappa B
- RNA, Small Interfering
- Receptors, Transforming Growth Factor beta
- SHC1 protein, human
- Shc Signaling Adaptor Proteins
- Src Homology 2 Domain-Containing, Transforming Protein 1
- Phosphotransferases
- FLT3 protein, human
- fms-Like Tyrosine Kinase 3
- Protein Serine-Threonine Kinases
- I-kappa B Kinase
- IKBKB protein, human
- Receptor, Transforming Growth Factor-beta Type II
- Phosphoric Monoester Hydrolases
|
Topics |
- Biomarkers, Tumor
(genetics, metabolism)
- Carcinoma, Squamous Cell
(enzymology, genetics)
- Cell Line, Tumor
- Cell Proliferation
- Computational Biology
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Genetic Vectors
(genetics)
- High-Throughput Screening Assays
- Humans
- I-kappa B Kinase
(metabolism)
- Lentivirus
(genetics)
- Mouth Neoplasms
(enzymology, genetics)
- NF-kappa B
(metabolism)
- Phosphoric Monoester Hydrolases
(genetics, metabolism)
- Phosphotransferases
(genetics, metabolism)
- Protein Serine-Threonine Kinases
(antagonists & inhibitors)
- Protein Transport
- RNA, Small Interfering
(genetics)
- Receptor, Transforming Growth Factor-beta Type II
- Receptors, Transforming Growth Factor beta
(antagonists & inhibitors)
- Reproducibility of Results
- Shc Signaling Adaptor Proteins
(metabolism)
- Signal Transduction
- Src Homology 2 Domain-Containing, Transforming Protein 1
- fms-Like Tyrosine Kinase 3
(antagonists & inhibitors)
|